Upcoming Events
Neurotorium will be at the 12th Congress of the European Academy of Neurology (EAN)
Neurotorium is hosting a special session at the EAN Congress on Precision Medicine in Brain Diseases
June 27, 2026
In this joint EAN–Neurotorium session, leading experts in neurology will come together to discuss the latest advances in precision medicine in various brain diseases.
Held as part of the EAN Congress 2026, this session will explore how precision medicine principles can be applied across diverse neurological conditions, including Parkinson’s disease (PD), dementias, and epilepsy. Join Professors James Rowe, Deb Pal, Ira Haraldsen, and Eva Schaeffer in their discussion on how precision medicine can transform neurology, within PD prevention, AI-driven dementia biomarker discovery, experimental medicine predictions of drug response, and genetic strategies in epilepsy care.
This session is scheduled for June 27, at 11.00 am CET during the EAN Congress.
Neurotorium is hosting a scientific session at the FENS Forum 2026
Neurotorium’s session is titled ‘Decoding Brain Diseases: Inflammation, Immunology, and Body-Brain Interactions‘
July 6, 2026
Neurotorium is organizing a special interest event titled “Decoding Brain Diseases: Inflammation, Immunology, and Body-Brain Interactions” at the 2026 Federation of European Neuroscience Societies (FENS) Forum.
This scientific session will feature experts examining inflammatory and immunological mechanisms in brain diseases, Professors Michael Heneka (Luxembourg), Tarja Malm (Finland), Séverine Boillée (France), and Golam Khandaker (UK), who will present their work in Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS), depression, schizophrenia, and neurodegeneration, with implications for novel interventions.
Don’t miss this session scheduled for the first day of the Forum, July 6, at 12.15 CET, in Hall H.
Neurotorium is attending the ECNP Congress 2026 with a Campfire Session
Neurotorium will be at the ECNP Congress, Europe’s largest meeting on applied and translational neuroscience
Oct 11, 2026
Neurotorium will participate in the 39th ECNP Congress in Munich, Germany, and host a Campfire Session titled “Embracing the Unique Qualities of Perinatal Depression to Achieve Better Clinical Outcomes” on October 11, at 12:50 CEST. This cross-disciplinary campfire session, led by Professors Dr. Julia Sacher (Germany) and Dr. Alkistis Skalkidou (Sweden), will be an in-person-only event where participants can ask the experts their questions about the distinct features of perinatal depression, its diagnosis, treatment strategies, and how to improve care. At the ECNP Campfire sessions, participants gathered in a circle — as if around a campfire — without slides or screens, for an engaging, interactive conversation. Join us on October 11, at 12.50 CEST!
Past Events
Neurotorium was at the 5th World Association of Stress-Related and Anxiety Disorders Congress
Neurotorium presented its new theme on Anxiety Disorders at the WASAD Congress
Oct 23-25, 2025
Neurotorium participated in the WASAD Congress, themed “Uncertainty in Times of Change: A Lifecourse Approach to Stress and Anxiety.” This year’s congress explored how stress and anxiety disorders develop and impact individuals across different stages of life.
At this event, Neurotorium introduced its new theme on Anxiety Disorders, featuring six educational slide decks that cover diagnosis, epidemiology, neurobiology, comorbidities, prognosis, and treatment. The theme highlights state-of-the-art research developed in collaboration with leading experts, along with free downloadable materials, including illustrations.
Neurotorium was at the 38th ECNP Congress with a Campfire Session
Neurotorium hosted a Campfire Session on Bipolar Disorder
Oct 12, 2025
Neurotorium hosted a campfire session on Bipolar Disorder at the European College of Neuropsychopharmacology (ECNP) Congress in October 2025, focusing on how precision medicine and measurement-based care can improve diagnosis and treatment for persons living with bipolar disorders. The ECNP campfire sessions are only available to in-person participants, allowing for maximum interaction between experts and participants on a specific topic. In these unique sessions, participants gathered in a circle — as if around a campfire — without the use of slides or screens, for an engaging and interactive conversation. This format was a perfect opportunity to ask questions directly to Professors Lakshmi Yatham and Christoph Correll from the Neurotorium Editorial Board.
Neurotorium organized and hosted an expert meeting on Advances in Cognition in Brain Disorders
Neurotorium held an expert meeting on Advances in Cognition in Brain Disorders
Oct 09-10, 2025
Neurotorium brought together world-leading experts from psychiatry and neurology for an extraordinary expert meeting on Advances in Cognition in Brain Disorders, held October 9-10, 2025, in Amsterdam.
In this invitation-only meeting, co-chaired by Professors Lakshmi Yatham and Matthew Kiernan from the Neurotorium Editorial Board, experts discussed the advances in:
- Cognition in Brain Disorders – Definition, Assessment, and Tools
- Biomarkers Associated with Cognitive Impairments
- Treatment Targets for Cognition in Brain Disorders
- Clinical Trial Design Issues, examples from Neurology and Psychiatry, and Potential solutions
The next step is to develop peer-reviewed manuscripts on these topics, led by the distinguished specialists from both disciplines.
Neurotorium hosted a Scientific Session at the 2025 World Congress of Biological Psychiatry in Berlin, Germany
Neurotorium’s scientific symposium was titled ‘Pathways to Precision Psychiatry‘
Sep 11, 2025
Neurotorium organised and hosted a scientific symposium at the World Congress of Biological Psychiatry of the WFSBP, featuring three international expert speakers who discussed advances in research in precision psychiatry aimed at improving psychiatric care through more personalised and targeted approaches. Speakers presented their work on various biological markers, immune and metabolic factors, and how these insights can guide better diagnoses and effective treatment strategies in mental health care. The chair of the session was Professor Dr. Lakshmi Yatham from the Neurotorium Editorial Board.
Neurotorium was the philanthropic partner to the Asian and Oceanian Parkinson’s Disease and Movement Disorders Congress (AOPMC) 2025
Neurotorium presented the updated educational materials on Parkinson’s disease at the AOPMC
March 21-23, 2025
Neurotorium attended the Asian and Oceanian Parkinson’s Disease and Movement Disorders Congress (AOPMC). We presented the updated educational materials on Parkinson’s disease. Additionally, during the congress, we provided attendees with the opportunity to meet Professor Dr. Shen-Yang Lim, neurologist and professor at the University of Malaya, in Kuala Lumpur, Malaysia.
Neurotorium hosted a scientific session at the Neuroscience Academy Denmark (NAD) Annual Meeting in 2024
Neurotorium organized a scientific session on Parkinson’s Disease
Oct 29, 2024
Parkinson’s disease (PD) is not a single, uniform disease; it is recognized as a heterogeneous, multi-system disorder that presents with both motor and non-motor symptoms, including autonomic dysfunction, sleep disturbances, psychiatric issues, and dementia. The disease is characterized by the spread of aggregated protein pathology, known as Lewy pathology, which propagates from neuron to neuron in a prion-like manner, affecting both the central nervous system (CNS) and the peripheral autonomic nervous system. Dr. Per Borghammer’s presentation covered essential aspects of the current understanding of PD and related disorders, such as Dementia with Lewy bodies.
Over the past 2-3 decades, multiple mutations linked to PD have been identified, accounting for 15–25% of PD cases, while the remaining cases are classified as sporadic. Although rodent models exist for some of the mutations causing PD, research on sporadic forms of PD is hampered by a lack of cellular models. Dr. Shani Stern’s work differentiated dopaminergic neurons derived from the induced pluripotent stem cells (iPSCs) of PD patients with various mutations and those with sporadic PD. Her presentation covered the identified common neurophysiological phenotype in which neurons from PD patients exhibited a significant reduction in synaptic current rates compared to neurons derived from healthy controls.
Neurotorium was a philanthropic partner of the International Society for Bipolar Disorders (ISBD) Annual Conference 2024
Neurotorium presented the state-of-the-art educational materials on Bipolar Disorder at the ISBD Annual Conference 2024
Sep 29-Oct 1, 2024
Neurotorium attended the International Society for Bipolar Disorders (ISBD) Annual Conference. During the conference, we provided the attendees the opportunity to meet three leading experts in the Bipolar Disorder field at the Neurotorium desk:
- Dr. Gomes on Sunday, September 29th, from 1.30-2 pm
- Dr. Yatham on Monday, September 30th, from 11:30-12 pm
- Dr. Kjærstad on Tuesday, October 1st, from 10-10.30 am
During the conference, the Neurotorium team was in the exhibit area of Floi, presenting the state-of-the-art educational materials on Bipolar Disorders.
Neurotorium organized and hosted a session at the Federation of European Neuroscience Societies (FENS) Forum 2024
Neurotorium organised an educational session on the potential of artificial intelligence (AI) and virtual reality (VR) to treat, diagnose, and reveal mechanisms of mental illnesses
June 27-29, 2024
Neurotorium’s session at the FENS Forum hosted two lectures that closed with a moderated discussion. Professor Emanuel Schwarz presented his work on using AI-based analysis of multiple high-dimensional data resources to understand the complex biology of mental disorders. His research aims to identify and characterize the biological and environmental factors that affect susceptibility to these disorders, capture their trajectories across the lifespan, and investigate their mechanisms.
Professor Louise Glenthøj’s talk was on the use of VR in the treatment of serious mental illnesses. VR technology allows individuals to immerse themselves in realistic environments while offering a safe, controlled space to address symptoms and improve mental functioning. VR simulations can be used to perform activities that may be challenging in the real world, creating new possibilities for optimizing therapeutic interventions in a potentially cost-effective manner.
Neurotorium attended the European Stroke Organization Conference (ESOC) in 2024
Neurotorium presented state-of-the-art educational materials on stroke at the ESOC 2024
May 25-17, 2024
European Stroke Organisation Conference (ESOC) celebrated its 10th year with attendance of more than 4000 participants. Neurotorium attended the conference to engage with stroke clinicians and raise awareness of the new Neurotorium theme on Neurobehavioural Consequences of Stroke (NBCS).
Expert Meetings
Neurotorium organized and hosted an expert meeting on Bipolar Disorder
Neurotorium regularly organises expert meetings, gathering the leading experts in a specific field to facilitate dialogue and progress in that field. The expert meeting in 2023 brought together established leaders and rising stars in the field of bipolar disorder, laying the foundation for our new theme on Bipolar Disorder.
Contact Neurotorium
We are eager to hear from you!
If you have participated in one of our outreach activities feel free to give us feedback.
For more frequent updates, follow us on our social media channels and sign up for our newsletter. You will find the links at the bottom of the page.
Our Partners
